A randomised, double-blind, placebo-controlled, 6-month study of the efficacy and safety of memantine in patients with PDD or DLB

被引:0
|
作者
Emre, M. [1 ]
机构
[1] Istanbul Univ, Dept Neurol, Behav Neurol & Movement Disorders Unit, Istanbul Fac Med, Istanbul, Turkey
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:338 / 338
页数:1
相关论文
共 50 条
  • [1] Memantine treatment in patients with mild to moderate Alzheimer's disease: Results of a randomised, double-blind, placebo-controlled 6-month study
    Bakchine, S.
    Loft, H.
    JOURNAL OF ALZHEIMERS DISEASE, 2008, 13 (01) : 97 - 107
  • [2] Memantine treatment in patients with mild to moderate Alzheimer's disease: Results of a randomised, double-blind, placebo-controlled 6-month study
    Bakchine, S.
    Loft, H.
    JOURNAL OF ALZHEIMERS DISEASE, 2007, 11 (04) : 471 - 479
  • [3] Efficacy and safety of faecal microbiota transplantation in patients with psoriatic arthritis: protocol for a 6-month, double-blind, randomised, placebo-controlled trial
    Kragsnaes, Maja Skov
    Kjeldsen, Jens
    Horn, Hans Christian
    Munk, Heidi Lausten
    Pedersen, Finn Moeller
    Holt, Hanne Marie
    Pedersen, Jens Kristian
    Holm, Dorte Kinggaard
    Glerup, Henning
    Andersen, Vibeke
    Fredberg, Ulrich
    Kristiansen, Karsten
    Christensen, Robin
    Ellingsen, Torkell
    BMJ OPEN, 2018, 8 (04):
  • [4] A 6-month study of the efficacy and safety of tadalafil in the treatment of erectile dysfunction: A randomised, double-blind, parallel-group, placebo-controlled study in Australian men
    McMahon, CG
    Stuckey, BGA
    Lording, DW
    Wittert, GA
    Murphy, A
    Shin, J
    Sutherland, PD
    Palmer, NR
    Lowy, MP
    Jesudason, DR
    Fredlund, P
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (02) : 143 - 149
  • [5] Efficacy of memantine in the treatment of fibromyalgia: A double-blind, randomised, controlled trial with 6-month follow-up
    Olivan-Blazquez, Barbara
    Herrera-Mercadal, Paola
    Puebla-Guedea, Marta
    Perez-Yus, Mari-Cruz
    Andres, Eva
    Fayed, Nicolas
    Lopez Del Hoyo, Yolanda
    Magallon, Rosa
    Roca, Miquel
    Garcia-Campayo, Javier
    PAIN, 2014, 155 (12) : 2517 - 2525
  • [6] EFFICACY AND SAFETY OF LINAGLIPTIN IN BLACK/AFRICAN AMERICAN PATIENTS WITH TYPE 2 DIABETES: A 6-MONTH, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Thrasher, James
    Daniels, Kristen
    Patel, Sanjay
    Whetteckey, Jacqueline
    Woerle, Hans-Juergen
    ENDOCRINE PRACTICE, 2014, 20 (05) : 412 - 420
  • [7] Efficacy and tolerability of gaboxadol in elderly patients with chronic primary insomnia: A 6-month double-blind, placebo-controlled outpatient study
    Hedner, J.
    Loft, H.
    Hajak, G.
    Lundahl, J.
    Hedegaard, K.
    Knoth, Sorensen H.
    Torstenson, R.
    SLEEP, 2007, 30 : A252 - A253
  • [8] A 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease
    Winblad, B.
    Grossberg, G.
    Frolich, L.
    Farlow, M.
    Zechner, S.
    Nagel, J.
    Lane, R.
    NEUROLOGY, 2007, 69 : S14 - S22
  • [9] EFFECT OF COLLAGEN HYDROLYSATE IN ARTICULAR PAIN: A 6-MONTH RANDOMISED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY
    Bruyere, O.
    Zegels, B.
    Leonori, L.
    Rabenda, V.
    Janssen, A.
    Bourges, C.
    Reginster, J. Y.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S362 - S363
  • [10] Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trial
    Walsh, Jennifer S.
    Marshall, Helen
    Smith, Isabelle L.
    Greenfield, Diana M.
    Swain, Jayne
    Best, Emma
    Ashton, James
    Brown, Julia M.
    Huddart, Robert
    Coleman, Robert E.
    Snowden, John A.
    Ross, Richard J.
    PLOS MEDICINE, 2019, 16 (11)